(I-BusinessNews.Com, August 06, 2020 ) The report “Plant Breeding and CRISPR Plants Market by Type (Conventional and Biotechnological [Hybrid, Molecular Breeding, GM, Genome Editing]), Trait (Herbicide Tolerance, Disease Resistance, and Yield Improvement), Application, and RegionÂGlobal Forecast to 2023″ The plant breeding and CRISPR plants market is projected to reach USD 14.6 billion by 2023, from USD 7.6 billion in 2018, at a CAGR of 13.95% during the forecast period. The market is driven by factors such as the growing need for high-quality crops and increased yield, and rising application of plant biotechnology in the agriculture industry.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256910775
On the basis of type, the biotechnological method is projected to witness the fastest growth in the plant breeding and CRISPR plants market during the forecast period
The increasing adoption of hybrid and molecular breeding techniques in developing countries and the growing cultivation of GM crops in the Americas are factors contributing to its high growth. The growing market for crop genetics in various countries of the Americas and the declining cost of genetic procedures in the past decade are factors driving the demand for genetic engineering and genome editing in the region. Unlike genetic techniques, no regulations are implied by the government for molecular breeding across the globe, which is projected to drive the growth of the biotechnological method at a higher rate during the forecast period. Advances in the field of CRISPR gene editing technology have brought about the third revolution in crop improvement and these tools can be used along with existing technologies. Growing innovation would facilitate the growth of CRISPR technology in agriculture, especially in countries such as the US, China, Japan, Brazil, and South Africa.
On the basis of trait, the herbicide tolerance segment is projected to witness the fastest growth in the plant breeding and CRISPR plants market
Increasing regulations on the use of chemical pesticides and rising instances of pest attacks during the early germination phase have increased the need for pesticide-tolerant seeds. Herbicide tolerance has been one of the major traits targeted by plant genetic companies for transgenic and non-transgenic crops. Non-transgenic Clearfield herbicide tolerance technology, developed by BASF and Syngenta, is recognized as one of the groundbreaking innovations in hybrid breeding technology, and more companies have exhibited their interest to enter this industry, which is projected to contribute to the growth in the next five years.
North America is estimated to dominate the market in 2018, while the Asia Pacific is projected to witness the fastest growth through 2023.
The increasing industrial value for corn and soybean in the US has been encouraging breeders to adopt advanced technologies for better yield, owing to which the adoption rate for crop genetics in this country has been high. Also, the limited regulatory control and high promotional support for intellectual property affairs in genetic technology have been extremely favorable toward the adoption of plant biotechnological tools in agriculture. Hence, North America dominated the global plant breeding market in 2017. On the other hand, there has been an ever-increasing demand for commercial seeds in the Asian market, in line with the improving economic conditions. Also, seed manufacturers such as Bayer, Monsanto, and Syngenta have been showing increasing interest in tapping this potential market, wherein the companies have been expanding their R&D centers across the Asia Pacific.
This report includes a study of development strategies of leading companies. The scope of this report includes a detailed study of major seed manufacturers that have in-house plant breeding facilities; these companies include players such as Bayer (Germany), Syngenta (Switzerland), DowDuPont (US), KWS SAAT (Germany), Limagrain (France), and DLF Trifolium (Denmark), and also major service providers, such as Eurofins (Luxembourg), SGS SA (Switzerland), Pacific Biosciences (US), Benson Hill Systems (US), Hudson River Biotechnology (US), Evogene (Israel), Bioconsortia (US), and Equinom (Israel).
MarketsandMarketsÂ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companiesÂ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarketsÂ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarketsÂ are tracking global high growth markets following the “Growth Engagement Model Â GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketsÂ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarketsÂ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarketsÂs flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra